Brighter - Recent capital injection to fuel first sales
Towards the tail-end of 2018, Brighter received ~SEK48m of capital injections from a number of sources, mostly from its management incentives programme, and an additional SEK5m in early 2019. The company intends to utilise these proceeds to drive commercialisation in regions of the Gulf Cooperation Council (GCC), specifically the United Arab Emirates (UAE). In December, the company announced that all the technical documentation has been submitted for the CE marking process.Brighter publ AB is a Sweden-based company active in the healthcare sector. It is primarily engaged in the development of Brighter One, a self-care device dedicated for type 1 and type 2 diabetes patients. Brighter One integrates a lancet, blood glucose meter for test strips, dosing and injection mechanism, and storage of glucose level and dosing history data. The Company cooperates with partners such as Almi Foretagspartner AB and Innovationsbron, as well as a distributor Rubin Medical.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.